- Home
- LPTX vs AXIL Comparison
LPTX vs AXIL Comparison
Compare LPTX & AXIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- AXIL
- Stock Information
- Founded
- LPTX 2011
- AXIL 2015
- Country
- LPTX United States
- AXIL United States
- Employees
- LPTX N/A
- AXIL N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- AXIL Package Goods/Cosmetics
- Sector
- LPTX Health Care
- AXIL Consumer Discretionary
- Exchange
- LPTX Nasdaq
- AXIL Nasdaq
- Market Cap
- LPTX 35.4M
- AXIL 36.8M
- IPO Year
- LPTX N/A
- AXIL N/A
- Fundamental
- Price
- LPTX $0.48
- AXIL $5.44
- Analyst Decision
- LPTX Hold
- AXIL
- Analyst Count
- LPTX 1
- AXIL 0
- Target Price
- LPTX N/A
- AXIL N/A
- AVG Volume (30 Days)
- LPTX 7.7M
- AXIL 14.8K
- Earning Date
- LPTX 11-13-2025
- AXIL 10-07-2025
- Dividend Yield
- LPTX N/A
- AXIL N/A
- EPS Growth
- LPTX N/A
- AXIL N/A
- EPS
- LPTX N/A
- AXIL 0.15
- Revenue
- LPTX N/A
- AXIL $27,262,468.00
- Revenue This Year
- LPTX N/A
- AXIL N/A
- Revenue Next Year
- LPTX N/A
- AXIL N/A
- P/E Ratio
- LPTX N/A
- AXIL $37.27
- Revenue Growth
- LPTX N/A
- AXIL 0.07
- 52 Week Low
- LPTX $0.22
- AXIL $3.54
- 52 Week High
- LPTX $4.79
- AXIL $10.75
- Technical
- Relative Strength Index (RSI)
- LPTX 47.84
- AXIL 40.99
- Support Level
- LPTX $0.43
- AXIL $5.04
- Resistance Level
- LPTX $0.56
- AXIL $6.24
- Average True Range (ATR)
- LPTX 0.06
- AXIL 0.61
- MACD
- LPTX -0.02
- AXIL -0.04
- Stochastic Oscillator
- LPTX 16.04
- AXIL 7.65
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.
About AXIL AXIL Brands Inc. Common Stock
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.